Ozuah Philip 4

What Happened

• Philip Ozuah, a director of Organon & Co. (OGN), received a grant of 17,857.143 phantom stock units on June 12, 2026. The units were valued at $13.44 each, for a total economic value of $240,000. The grant is reported as a derivative award (A).

Key Details

• Transaction date: 2026-06-12; Filing date: 2026-06-15 (filed within reporting deadline).
• Grant: 17,857.143 phantom stock units at $13.44 per unit; total reported value $240,000.
• Shares owned after transaction: total holdings after this grant are not specified in the filing. The filing notes holdings include phantom units from dividend reinvestments on 2025-09-11, 2025-12-11, 2026-03-12 and 2026-06-11 (Footnote F3).
• Notable footnotes:
  • F1: Each phantom stock unit is economically equivalent to one share of Organon common stock (1-for-1).
  • F2: Units were granted under the Organon Non‑Employee Director Savings Plan and are payable in cash upon settlement after the director’s service terminates.
  • F3: Prior phantom units include dividend reinvestment transactions on listed dates.
• Transaction type: Award/grant (A) — not an open‑market purchase or sale.

Context

• These phantom stock units are a form of director compensation and are derivative/phantom units (not immediately tradable shares). They mirror the economic value of common stock but, per the plan, will be paid in cash when settled after the director’s service ends. Such grants are routine for non‑employee directors and do not by themselves indicate a buy/sell decision in the open market.